Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Oncotarget
|
December 2, 2017
Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
In Ho Song, Youn Noh, Junhye Kwon, et al.
Lancet (London, England)
|
November 17, 2019
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
Désirée van der Heijde, In-Ho Song, Aileen L Pangan, et al.
Theranostics
|
February 28, 2019
Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
Min Woo Kim, Hwa Yeon Jeong, Seong Jae Kang, et al.
RMD Open
|
July 27, 2022
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
Désirée van der Heijde, Atul Deodhar, Walter P Maksymowych, et al.
Molecular Pharmaceutics
|
December 30, 2022
Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [<sup>18</sup>F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
Su Bin Kim, In Ho Song, Seon Yoo Kim, et al.
Scientific Reports
|
August 27, 2017
Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles
Min Woo Kim, Hwa Yeon Jeong, Seong Jae Kang, et al.
Arthritis Research & Therapy
|
February 5, 2025
Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
Filip Van den Bosch, Atul Deodhar, Denis Poddubnyy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2016
Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
In Ho Song, Tae Sup Lee, Yong Serk Park, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 2018
Development of <sup>64</sup>Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies
Sang-Keun Woo, Su Jin Jang, Min-Jung Seo, et al.
RMD Open
|
March 25, 2022
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials
Iain B McInnes, Andrew J K Ostor, Philip J Mease, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Oncotarget
|
December 2, 2017
Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
In Ho Song, Youn Noh, Junhye Kwon, et al.
Lancet (London, England)
|
November 17, 2019
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
Désirée van der Heijde, In-Ho Song, Aileen L Pangan, et al.
Theranostics
|
February 28, 2019
Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
Min Woo Kim, Hwa Yeon Jeong, Seong Jae Kang, et al.
RMD Open
|
July 27, 2022
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
Désirée van der Heijde, Atul Deodhar, Walter P Maksymowych, et al.
Molecular Pharmaceutics
|
December 30, 2022
Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [<sup>18</sup>F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
Su Bin Kim, In Ho Song, Seon Yoo Kim, et al.
Scientific Reports
|
August 27, 2017
Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles
Min Woo Kim, Hwa Yeon Jeong, Seong Jae Kang, et al.
Arthritis Research & Therapy
|
February 5, 2025
Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
Filip Van den Bosch, Atul Deodhar, Denis Poddubnyy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2016
Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
In Ho Song, Tae Sup Lee, Yong Serk Park, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 2018
Development of <sup>64</sup>Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies
Sang-Keun Woo, Su Jin Jang, Min-Jung Seo, et al.
RMD Open
|
March 25, 2022
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials
Iain B McInnes, Andrew J K Ostor, Philip J Mease, et al.
Page
of 11